Sign in Subscribe
Cardiology

LeMaitre Vascular Expands into Asia with New Japanese Subsidiary

Strategic Insights

— 1 min read

LeMaitre Vascular, a leader in vascular medical devices, has opened its Japanese subsidiary in Tokyo to serve as the hub for sales, marketing, and product shipments to customers in Japan, Korea, and Taiwan. The new subsidiary, LeMaitre Vascular KK, will be led by Toshihito Seto, recently appointed director of Asian operations. This strategic move provides direct access to emerging markets with a population of approximately 190 million and is expected to contribute significantly to the company's financial targets.

Key Takeaways:

  • LeMaitre Vascular has established a 2200 square foot Japanese subsidiary in Tokyo to serve as the headquarters for sales, marketing, and product shipments.
  • The subsidiary, LeMaitre Vascular KK, will be led by Toshihito Seto, director of Asian operations, and will serve as the focal point for the company's Asian operations.
  • The company plans to launch the recently acquired AnastoClip vessel closure system at two Japanese medical congresses in October and expects to register its first sales by the end of 2004.
  • Currently, only half of LeMaitre Vascular's product lines are approved for sale in Japan, while only two are registered for sale in Korea, and none are approved in Taiwan.
  • The Japanese subsidiary is expected to be a significant contributor to the company's financial targets, particularly due to the vast population of the Asian region.
  • The company will allocate resources to the Japanese subsidiary in 2005 to build sales channels and obtain regulatory approvals for product lines not yet approved for sale.

Statistics:

  • The Japanese subsidiary is located in a 2200 square foot facility in Tokyo.
  • The company expects to register its first sales by the end of 2004.
  • Currently, 50% of LeMaitre Vascular's product lines are approved for sale in Japan.
  • Only 2 product lines are registered for sale in Korea.
  • No product lines are approved for sale in Taiwan.
  • The Asian region has a population of approximately 190 million.

Sources:

  • "LeMaitre Vascular Announces Opening of Japanese Subsidiary" (Heart Disease Weekly, 2004)

Read more